Poolbeg Pharma Plc
🇬🇧United Kingdom
Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Effects of p38 MAPK Inhibitor POLB 001 on in Vivo LPS Challenge Responses
- First Posted Date
- 2023-03-13
- Last Posted Date
- 2023-03-14
- Lead Sponsor
- Poolbeg Pharma plc
- Target Recruit Count
- 36
- Registration Number
- NCT05765955
- Locations
- 🇳🇱
Centre for Human Drug Research, Leiden, Netherlands
News
No news found